Intermede Investment Partners Ltd lowered its position in Stericycle Inc. (NASDAQ:SRCL) by 33.8% during the second quarter, Holdings Channel reports. The fund owned 153,583 shares of the company’s stock after selling 78,348 shares during the period. Stericycle makes up 1.9% of Intermede Investment Partners Ltd’s holdings, making the stock its 27th largest position. Intermede Investment Partners Ltd’s holdings in Stericycle were worth $15,991,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Jana Partners LLC acquired a new position in shares of Stericycle during the first quarter worth about $305,997,000. First Republic Investment Management Inc. raised its position in shares of Stericycle by 23.9% in the first quarter. First Republic Investment Management Inc. now owns 296,838 shares of the company’s stock worth $37,457,000 after buying an additional 57,220 shares during the period. Douglas Lane & Associates LLC raised its position in shares of Stericycle by 6.6% in the second quarter. Douglas Lane & Associates LLC now owns 346,276 shares of the company’s stock worth $36,054,000 after buying an additional 21,370 shares during the period. Oakbrook Investments LLC acquired a new position in shares of Stericycle during the second quarter worth about $13,871,000. Finally, Geode Capital Management LLC raised its position in shares of Stericycle by 2.7% in the first quarter. Geode Capital Management LLC now owns 729,638 shares of the company’s stock worth $91,897,000 after buying an additional 19,379 shares during the period. 92.80% of the stock is currently owned by institutional investors.
Stericycle Inc. (NASDAQ:SRCL) traded up 0.65% on Tuesday, hitting $80.26. The stock had a trading volume of 1,322,625 shares. The stock has a 50-day moving average of $83.69 and a 200-day moving average of $101.59. Stericycle Inc. has a one year low of $76.76 and a one year high of $151.57. The company has a market cap of $6.83 billion, a PE ratio of 28.25 and a beta of 0.27.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.18. The business had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The business’s revenue was up 24.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.14 EPS. Equities analysts expect that Stericycle Inc. will post $4.67 earnings per share for the current fiscal year.
A number of brokerages have recently issued reports on SRCL. Zacks Investment Research lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research report on Monday, July 25th. Imperial Capital lowered shares of Stericycle from an “in-line” rating to an “underperform” rating and lowered their target price for the stock from $100.00 to $93.50 in a research report on Friday, July 29th. Jefferies Group restated a “buy” rating and set a $125.00 target price (down from $140.00) on shares of Stericycle in a research report on Friday, July 29th. Wellington Shields lowered shares of Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Finally, Macquarie began coverage on shares of Stericycle in a research report on Thursday, August 25th. They issued a “neutral” rating and a $96.00 price objective on the stock. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $104.95.
In related news, Director Rodney F. Dammeyer sold 10,188 shares of the company’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total transaction of $871,074.00. Following the sale, the director now directly owns 10,188 shares of the company’s stock, valued at approximately $871,074. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the sale, the executive vice president now directly owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. Corporate insiders own 3.30% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.